GlaxoSmithKline Pharmaceuticals Limited Share Price NSE India S.E.

Equities

GLAXO

INE159A01016

Pharmaceuticals

Market Closed - NSE India S.E. 12:47:11 18/05/2024 pm IST 5-day change 1st Jan Change
2,360 INR +3.17% Intraday chart for GlaxoSmithKline Pharmaceuticals Limited +18.02% +24.31%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 3.45TCr 41Cr Sales 2025 * 3.65TCr 44Cr Capitalization 39TCr 466.23Cr
Net income 2024 590Cr 7.09Cr Net income 2025 * 767.8Cr 9.22Cr EV / Sales 2024 9.53 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 10.6 x
P/E ratio 2024
55.8 x
P/E ratio 2025 *
50.6 x
Employees 3,680
Yield 2024 *
1.32%
Yield 2025 *
1.38%
Free-Float 24.42%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.17%
1 week+18.02%
Current month+13.07%
1 month+24.97%
3 months+4.60%
6 months+43.18%
Current year+24.31%
More quotes
1 week
1 967.80
Extreme 1967.8
2 401.35
1 month
1 854.00
Extreme 1854
2 401.35
Current year
1 842.05
Extreme 1842.05
2 524.00
1 year
1 277.10
Extreme 1277.1
2 524.00
3 years
1 227.00
Extreme 1227
2 524.00
5 years
962.65
Extreme 962.65
2 524.00
10 years
962.65
Extreme 962.65
2 524.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 01/22/01
Director of Finance/CFO - 01/22/01
Compliance Officer - -
Members of the board TitleAgeSince
Chairman 70 01/19/01
Director/Board Member 64 16/22/16
Director/Board Member 74 30/15/30
More insiders
Date Price Change Volume
18/24/18 2,360 +3.17% 126 099
17/24/17 2,287 +13.08% 1,198,663
16/24/16 2,022 +1.68% 110,541
15/24/15 1,989 -0.27% 84,411
14/24/14 1,994 -0.25% 36,943

Delayed Quote NSE India S.E., May 18, 2024 at 12:47 pm IST

More quotes
GlaxoSmithKline Pharmaceuticals Limited is an India-based global healthcare company. The Company is engaged in the business of manufacturing, distributing and trading in pharmaceuticals. It has three product areas: vaccines, specialty and general medicines. Its general medicines business has a portfolio of medicines in anti-infectives, pain, dermatology and vitamins. Its general medicines brands include Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact and Physiogel. Its T-bact brand products are used in specific types of bacterial skin infections. The Company's vaccine brands include Shingrix, Infanrix Hexa, Synflorix, Boostrix, Havrix, Menveo, Fluarix Tetra and Varilrix. Its specialty medicines business is focused on developing medicines for respiratory diseases and human immunodeficiency virus. The Company is also building its presence in other therapeutic areas, such as immunology and oncology. Its specialty medicines brands include Nucala and Trelegy Ellipta.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
2,292 INR
Average target price
2,141 INR
Spread / Average Target
-6.56%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW